Idarubicin vs. Epirubicin TACE in the Treatment of Hepatocellular Carcinoma

NCT05053386 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

186

Enrollment

OTHER

Sponsor class

Conditions

Hepatocellular Carcinoma

Interventions

DRUG: Idarubicin Hydrochloride for Injection
DRUG: Epirubicin

Sponsor

Zhejiang Cancer Hospital